Tejas Savant
Stock Analyst at Morgan Stanley
(0.67)
# 2449
Out of 5,370 analysts
298
Total ratings
33.59%
Success rate
-9.79%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
CTKB Cytek Biosciences | Maintains: Equal-Weight | 9 7 | 3.31 | 111.48% | 9 | May 28, 2025 | |
TXG 10x Genomics | Maintains: Overweight | 26 18 | 11.03 | 63.19% | 14 | May 19, 2025 | |
ILMN Illumina | Maintains: Equal-Weight | 136 100 | 90.09 | 11% | 8 | May 12, 2025 | |
TEM Tempus AI | Maintains: Overweight | 60 65 | 71.99 | -9.71% | 3 | May 9, 2025 | |
HOLX Hologic | Maintains: Equal-Weight | 77 65 | 65.16 | -0.25% | 9 | May 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 8 7 | 6.91 | 1.3% | 2 | May 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 9 | 10.26 | -12.28% | 12 | May 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 17 10 | 7.4 | 35.14% | 13 | May 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 25 15 | 13.43 | 11.69% | 17 | Apr 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 5 | 2.15 | 132.56% | 13 | Mar 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 16 20 | 42.55 | -53% | 2 | Mar 18, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 176 185 | 168.2 | 9.99% | 13 | Mar 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 245 250 | 159.4 | 56.84% | 11 | Feb 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 647 678 | 404.82 | 67.48% | 14 | Jan 31, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Equal-Weight | 24 23 | 24.05 | -4.37% | 1 | Dec 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 26 28 | 26.66 | 5.03% | 12 | Nov 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 32 21 | 4.92 | 326.83% | 2 | Nov 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 4 2 | 1.38 | 44.93% | 11 | Aug 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 4 3 | 1.27 | 136.22% | 10 | Aug 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 80 40 | 9.14 | 337.64% | 2 | May 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 26 26 | n/a | n/a | 12 | Mar 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 14 8 | n/a | n/a | 11 | Oct 24, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 52 55 | n/a | n/a | 11 | Aug 30, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 1 | n/a | n/a | 1 | Aug 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 6 6 | 0.72 | 733.33% | 3 | Aug 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 11 10 | 2.91 | 243.64% | 8 | May 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 3 | 3.5 | -21.43% | 6 | Mar 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 11 5 | 6.45 | -22.48% | 12 | Feb 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 11 10 | 2.02 | 395.05% | 10 | Feb 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 80 73 | 49.13 | 48.59% | 9 | Feb 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 5 2 | n/a | n/a | 5 | Jan 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 10 8 | n/a | n/a | 4 | Aug 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 10 5 | n/a | n/a | 8 | Aug 10, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 350 250 | 151.28 | 65.26% | 1 | Aug 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 5 | n/a | n/a | 5 | May 12, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 17 19 | n/a | n/a | 3 | May 6, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 18 17 | n/a | n/a | 8 | May 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 21 20 | n/a | n/a | 2 | Mar 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 35 65 | n/a | n/a | 1 | Feb 22, 2021 |